Cronos Group Inc. (CRON) Reaches $8.41 After 3.00% Down Move; KKR & Co LP Has 1.07 Sentiment

March 14, 2018 - By Ellis Scott

The stock of Cronos Group Inc. (NASDAQ:CRON) is a huge mover today! The stock decreased 2.55% or $0.2199 during the last trading session, reaching $8.4101. About 1.65M shares traded. Cronos Group Inc. (NASDAQ:CRON) has 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.The move comes after 8 months negative chart setup for the $1.35 billion company. It was reported on Mar, 14 by We have $8.16 PT which if reached, will make NASDAQ:CRON worth $40.53M less.

KKR & Co. L.P. is a private equity and real estate investment firm specializing in direct and fund of fund investments in fintech sector. The company has market cap of $18.22 billion. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, and middle market investments. It has a 11.36 P/E ratio. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things , internet, information services, information technology infrastructure, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy.

Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The company has market cap of $1.35 billion. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations . It has a 1051.26 P/E ratio. The firm typically invests in companies based in Canada.

Since January 1, 0001, it had 1 insider buy, and 0 selling transactions for $10.52 million activity.

Valueact Holdings L.P. holds 9.28% of its portfolio in KKR & Co. L.P. for 45.56 million shares. Matthew 25 Management Corp owns 1.60 million shares or 9.07% of their US portfolio. Moreover, Walnut Private Equity Partners Llc has 7.15% invested in the company for 438,235 shares. The Virgin Islands – British-based Shanda Asset Management Holdings Ltd has invested 6.09% in the stock. Davis Capital Partners Llc, a California-based fund reported 2.50 million shares.

Analysts await KKR & Co. L.P. (NYSE:KKR) to report earnings on April, 26. They expect $0.61 EPS, down 6.15% or $0.04 from last year’s $0.65 per share. KKR’s profit will be $501.88 million for 9.08 P/E if the $0.61 EPS becomes a reality. After $0.48 actual EPS reported by KKR & Co. L.P. for the previous quarter, Wall Street now forecasts 27.08% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: